vs
InvenTrust Properties Corp.（IVT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
InvenTrust Properties Corp.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$77.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 3.4%，领先380.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 8.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.6%）
InvenTrust Properties Corp.是一家专注于购物中心投资的房地产投资信托基金，截至2024年12月31日，公司共持有68处物业的权益，总建筑面积达1100万平方英尺，在商业地产投资领域拥有成熟的运营布局与资产储备。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
IVT vs RIGL — 直观对比
营收规模更大
IVT
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出12.6%
8.6%
净利率更高
RIGL
高出380.6%
3.4%
两年增速更快
RIGL
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.4M | $69.8M |
| 净利润 | $2.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -11.0% | 33.2% |
| 净利率 | 3.4% | 384.0% |
| 营收同比 | 8.6% | 21.2% |
| 净利润同比 | -72.8% | 1769.2% |
| 每股收益（稀释后） | $0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVTRIGL
| Q4 25 | $77.4M | $69.8M | ||
| Q3 25 | $74.5M | $69.5M | ||
| Q2 25 | $73.6M | $101.7M | ||
| Q1 25 | $73.8M | $53.3M | ||
| Q4 24 | $71.2M | $57.6M | ||
| Q3 24 | $68.5M | $55.3M | ||
| Q2 24 | $67.4M | $36.8M | ||
| Q1 24 | $66.8M | $29.5M |
净利润IVTRIGL
| Q4 25 | $2.7M | $268.1M | ||
| Q3 25 | $6.0M | $27.9M | ||
| Q2 25 | $95.9M | $59.6M | ||
| Q1 25 | $6.8M | $11.4M | ||
| Q4 24 | $9.8M | $14.3M | ||
| Q3 24 | $-539.0K | $12.4M | ||
| Q2 24 | $1.5M | $-1.0M | ||
| Q1 24 | $2.9M | $-8.2M |
毛利率IVTRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率IVTRIGL
| Q4 25 | -11.0% | 33.2% | ||
| Q3 25 | -9.8% | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | -10.5% | 23.9% | ||
| Q4 24 | -3.6% | 28.9% | ||
| Q3 24 | -18.7% | 25.4% | ||
| Q2 24 | -13.6% | 1.2% | ||
| Q1 24 | -13.1% | -23.6% |
净利率IVTRIGL
| Q4 25 | 3.4% | 384.0% | ||
| Q3 25 | 8.1% | 40.2% | ||
| Q2 25 | 130.4% | 58.6% | ||
| Q1 25 | 9.2% | 21.5% | ||
| Q4 24 | 13.8% | 24.9% | ||
| Q3 24 | -0.8% | 22.5% | ||
| Q2 24 | 2.2% | -2.8% | ||
| Q1 24 | 4.3% | -27.9% |
每股收益（稀释后）IVTRIGL
| Q4 25 | $0.02 | $14.11 | ||
| Q3 25 | $0.08 | $1.46 | ||
| Q2 25 | $1.23 | $3.28 | ||
| Q1 25 | $0.09 | $0.63 | ||
| Q4 24 | $0.14 | $0.82 | ||
| Q3 24 | $-0.01 | $0.70 | ||
| Q2 24 | $0.02 | $-0.06 | ||
| Q1 24 | $0.04 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $825.9M | $52.5M |
| 股东权益账面价值 | $1.8B | $391.5M |
| 总资产 | $2.8B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.46× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资IVTRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务IVTRIGL
| Q4 25 | $825.9M | $52.5M | ||
| Q3 25 | $764.6M | $60.0M | ||
| Q2 25 | $746.3M | $60.0M | ||
| Q1 25 | $740.7M | $60.0M | ||
| Q4 24 | $740.4M | $60.0M | ||
| Q3 24 | $740.1M | $60.0M | ||
| Q2 24 | $812.2M | $60.0M | ||
| Q1 24 | $827.5M | $60.0M |
股东权益IVTRIGL
| Q4 25 | $1.8B | $391.5M | ||
| Q3 25 | $1.8B | $117.6M | ||
| Q2 25 | $1.8B | $81.9M | ||
| Q1 25 | $1.7B | $18.6M | ||
| Q4 24 | $1.8B | $3.3M | ||
| Q3 24 | $1.8B | $-14.6M | ||
| Q2 24 | $1.5B | $-29.9M | ||
| Q1 24 | $1.5B | $-31.7M |
总资产IVTRIGL
| Q4 25 | $2.8B | $513.6M | ||
| Q3 25 | $2.7B | $242.5M | ||
| Q2 25 | $2.7B | $206.7M | ||
| Q1 25 | $2.6B | $176.0M | ||
| Q4 24 | $2.6B | $164.0M | ||
| Q3 24 | $2.6B | $139.4M | ||
| Q2 24 | $2.5B | $128.4M | ||
| Q1 24 | $2.5B | $126.5M |
负债/权益比IVTRIGL
| Q4 25 | 0.46× | 0.13× | ||
| Q3 25 | 0.42× | 0.51× | ||
| Q2 25 | 0.41× | 0.73× | ||
| Q1 25 | 0.42× | 3.23× | ||
| Q4 24 | 0.42× | 18.25× | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.53× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $155.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $110.9M | — |
| 自由现金流率自由现金流/营收 | 143.3% | — |
| 资本支出强度资本支出/营收 | 57.5% | — |
| 现金转化率经营现金流/净利润 | 58.41× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $193.1M | — |
8季度趋势，按日历期对齐
经营现金流IVTRIGL
| Q4 25 | $155.4M | $22.0M | ||
| Q3 25 | $43.8M | $24.0M | ||
| Q2 25 | $48.7M | $30.5M | ||
| Q1 25 | $20.2M | $-893.0K | ||
| Q4 24 | $136.9M | $14.5M | ||
| Q3 24 | $38.4M | $21.7M | ||
| Q2 24 | $46.7M | $302.0K | ||
| Q1 24 | $14.8M | $-5.0M |
自由现金流IVTRIGL
| Q4 25 | $110.9M | — | ||
| Q3 25 | $31.4M | — | ||
| Q2 25 | $38.0M | — | ||
| Q1 25 | $12.8M | — | ||
| Q4 24 | $100.8M | — | ||
| Q3 24 | $29.3M | — | ||
| Q2 24 | $37.2M | — | ||
| Q1 24 | $7.7M | — |
自由现金流率IVTRIGL
| Q4 25 | 143.3% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 51.6% | — | ||
| Q1 25 | 17.4% | — | ||
| Q4 24 | 141.5% | — | ||
| Q3 24 | 42.8% | — | ||
| Q2 24 | 55.2% | — | ||
| Q1 24 | 11.5% | — |
资本支出强度IVTRIGL
| Q4 25 | 57.5% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 14.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 50.7% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 10.6% | — |
现金转化率IVTRIGL
| Q4 25 | 58.41× | 0.08× | ||
| Q3 25 | 7.27× | 0.86× | ||
| Q2 25 | 0.51× | 0.51× | ||
| Q1 25 | 2.97× | -0.08× | ||
| Q4 24 | 13.97× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
